Immuneering (IMRX) Net Equity Issued and Repurchased (2020 - 2026)
Immuneering's Net Equity Issued and Repurchased was $220,174 in Q3 2026, down 48.2% from $424,663 a year earlier but up 794.7% from the prior quarter.
Powered by 
Analysis
Immuneering (IMRX) Net Equity Issued and Repurchased (2020 - 2026) Analysis & Trends
On a trailing twelve-month basis, Immuneering's Net Equity Issued and Repurchased was $655,374 through Sep 30, 2026, up 16.9% year-over-year; for FY2025, it came in at $790,442, down 28.6% from FY2024.
- Net Equity Issued and Repurchased shows a five-year compound annual growth rate of -53.7% (FY2020 to FY2025).
- In earlier years, Net Equity Issued and Repurchased was $1.11 million in FY2024 (+148.9%), $444,838 in FY2023 (+48.1%), $300,379 in FY2022 (-99.8%) and $146.39 million in FY2021 (+293.5%).
- Quarterly Net Equity Issued and Repurchased has moved between -$28.18 million (Q3 2023) and $28.38 million (Q2 2023) over five years.
- Compared with a year earlier, Net Equity Issued and Repurchased was higher in two of the last four quarters, with growth averaging 33.6%.
- The best year-over-year quarter for Net Equity Issued and Repurchased over five years was Q4 2022 (growth of 459.9%); the worst was Q4 2021 (a decline of 100.0%).
- Per Business Quant data, IMRX's Net Equity Issued and Repurchased in the three quarters before Q3 2026 was $24,608 (Q2 2026), $180,760 (Q1 2026) and $229,832 (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | -377.00 Mn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | -966.00 Mn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | -5.00 Mn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | -406.00 Mn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 4.00 Mn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | - |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | -283.00 Mn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | - |
| 10 | Immuneering | 249.34 Mn | -375.49 Mn | - | 220,174.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 220,174.00 |
| Jun 30, 2026 | 24,608.00 |
| Mar 31, 2026 | 180,760.00 |
| Dec 31, 2025 | 229,832.00 |
| Sep 30, 2025 | 424,663.00 |
| Jun 30, 2025 | 2,055.00 |
| Mar 31, 2025 | 133,892.00 |
| Sep 30, 2024 | 127,187.00 |
| Mar 31, 2024 | 979,923.00 |
| Dec 31, 2023 | 7,835.00 |
| Sep 30, 2023 | -28.18 Mn |
| Jun 30, 2023 | 28.38 Mn |
| Mar 31, 2023 | 239,408.00 |
| Dec 31, 2022 | 42,098.00 |
| Sep 30, 2022 | 37,386.00 |
| Jun 30, 2022 | 27,784.00 |
| Mar 31, 2022 | 193,111.00 |
| Dec 31, 2021 | 7,519.00 |
| Sep 30, 2021 | 120.61 Mn |
| Dec 31, 2020 | 36.20 Mn |
API Access
Immuneering Net Equity Issued and Repurchased API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=IMRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-equity-issued-and-repurchased", "ticker": "IMRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=IMRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();